These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15522261)

  • 21. Gene expression profiling in a model of D-penicillamine-induced autoimmunity in the Brown Norway rat: predictive value of early signs of danger.
    Séguin B; Boutros PC; Li X; Okey AB; Uetrecht JP
    Chem Res Toxicol; 2005 Aug; 18(8):1193-202. PubMed ID: 16097792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The danger hypothesis applied to idiosyncratic drug reactions.
    Li J; Uetrecht JP
    Handb Exp Pharmacol; 2010; (196):493-509. PubMed ID: 20020274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and animal models of drug-induced blood dyscrasias.
    Ip J; Uetrecht JP
    Environ Toxicol Pharmacol; 2006 Feb; 21(2):135-40. PubMed ID: 21783650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune mechanisms of idiosyncratic drug-induced liver injury.
    Mak A; Uetrecht J
    J Clin Transl Res; 2017 Feb; 3(1):145-156. PubMed ID: 30873473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reactions to antibiotics and major antibiotic drug interactions.
    Novotný J; Novotný M
    Gen Physiol Biophys; 1999 Oct; 18 Spec No():126-39. PubMed ID: 10703731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonimmunologic adverse drug reactions. How to recognize and categorize some common reactions.
    Bernstein JA
    Postgrad Med; 1995 Jul; 98(1):120-2, 125-6. PubMed ID: 7603941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity.
    Park BK; Laverty H; Srivastava A; Antoine DJ; Naisbitt D; Williams DP
    Chem Biol Interact; 2011 Jun; 192(1-2):30-6. PubMed ID: 20846520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of preclinical testing for allergic side effects.
    Bala S; Weaver J; Hastings KL
    Toxicology; 2005 Apr; 209(2):195-200. PubMed ID: 15767036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From toxic precursors to safe drugs. Mechanisms and relevance of idiosyncratic drug reactions.
    Petersen KU
    Arzneimittelforschung; 2002; 52(6):423-9. PubMed ID: 12109041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of toxic metabolites during drug development.
    Park K; Williams DP; Naisbitt DJ; Kitteringham NR; Pirmohamed M
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):425-34. PubMed ID: 15996699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of the sequence of events involved in nevirapine-induced skin rash in Brown Norway rats.
    Popovic M; Caswell JL; Mannargudi B; Shenton JM; Uetrecht JP
    Chem Res Toxicol; 2006 Sep; 19(9):1205-14. PubMed ID: 16978025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DITOP: drug-induced toxicity related protein database.
    Zhang JX; Huang WJ; Zeng JH; Huang WH; Wang Y; Zhao R; Han BC; Liu QF; Chen YZ; Ji ZL
    Bioinformatics; 2007 Jul; 23(13):1710-2. PubMed ID: 17463030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The science of health technology assessment: the safety perspective.
    Shear NH
    Can J Clin Pharmacol; 2001; 8 Suppl A():24A-28A. PubMed ID: 11586375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of PD-1 functional knockout rats to study idiosyncratic adverse reactions to nevirapine.
    Cho T; Hayes A; Henderson JT; Uetrecht J
    Toxicol Sci; 2024 Aug; 200(2):382-393. PubMed ID: 38767978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development and characterization of a CRISPR/Cas9-mediated PD-1 functional knockout rat as a tool to study idiosyncratic drug reactions.
    Cho T; Wierk A; Gertsenstein M; Rodgers CE; Uetrecht J; Henderson JT
    Toxicol Sci; 2024 Mar; 198(2):233-245. PubMed ID: 38230816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successes and frustrations in developing animal models of idiosyncratic drug reactions.
    Roth RA; Ganey PE
    Chem Biol Interact; 2005 Apr; 152(2-3):165; author reply 167-8. PubMed ID: 15840389
    [No Abstract]   [Full Text] [Related]  

  • 39. How Reactive Metabolites Induce an Immune Response That Sometimes Leads to an Idiosyncratic Drug Reaction.
    Cho T; Uetrecht J
    Chem Res Toxicol; 2017 Jan; 30(1):295-314. PubMed ID: 27775332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.